Patients with malignant gliomas have a very poor prognosis. To explore a novel and more effective approach for the treatment of malignant gliomas, a strategy combining suicide gene therapy and radiation treatment (RT) was designed with insertion of a radio-inducible promoter. The plasmids used in ...
Glioblastoma (GBM) has high heterogeneity and resistance to radiotherapy and chemotherapy, and the median survival period after treatment is only 15 months. An important reason for the poor prognosis of GBM is the lack of effective early diagnosis and intervention....
The prognosis of PMBT patients admitted to the ICU appears relatively favorable compared to that of hematologic malignancies or solid tumors, especially when the patient is admitted for seizures. The presence of a PMBT, therefore, does not appear to be sufficient for refusal of ICU admission. ...
Among them, glioblastoma multiform (GBM) is the most common malignant primary brain tumor in adults with a poor prognosis of 5-year survival rate less than 5% following the standard therapy. In the past 17 years, the standard therapy of GBM has been surgery followed by radiation and the ...
The prognosis of the malignant type is poorly defined, with local recurrence occurring in 10鈥 40% and metastases in 10%. Chemotherapy and radiotherapy are generally ineffective in this tumor type. The most common metastatic sites for malignant cases are the lung and bones, but in rare ...
A new research paper titled "Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma" ... Jul 15, 2024 0 0 Oncology & Cancer Proteogenomics analysis of...
Addition of IFN-alpha to treatment of malignant brain tumors. Despite many attempts to improve the survival after surgery of patients with malignant astrocytoma the prognosis is poor. We have used natural IFN-卤 in 16... B Jereb,G Petric-Grabnar,B Klun,... - 《Acta Radiologica Therapy Phys...
Without this reagent,malignanttumours and various infectious diseases cannot be identified, which precludes the use of modern techniques for the diagnosis, prognosis[...] daccess-ods.un.org daccess-ods.un.org 如果没有这种试剂,就无法处理恶性肿瘤和其他传染性疾病,从而妨碍应用诊断、预后和治疗这些疾病...
Postoperative radiotherapy prolongs survival but is not curative and prognosis remains poor with only a few patients being alive 2years after diagnosis. Over the past decades multiple trials dealt with the question of whether chemotherapy (CT) may influence the outcome of malignant brain tumor ...